Related Experiment Video

Updated: Jul 23, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K

Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?

Luxiang Wang1,2, Chunli Zhang3, Shuang Fan4,5,6

  • 1Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai 200025, China.

Innovation (Cambridge (Mass.))
|July 14, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.1K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

Related Experiment Videos

Last Updated: Jul 23, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.1K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K

Articles linked to this work by shared authors, journal, and citation graph.

[Comparison of generative artificial intelligence and physicians in differential diagnosis and treatment planning based on initial hospital medical records].

Zhonghua wei zhong bing ji jiu yi xue·2026

Phosphorylation of the plant photoreceptor UVR8 regulates its dimer/monomer status and enhances UV-B signaling across species.

The Plant cell·2026

Iron-Driven Ferroptosis in Diabetic Kidney Disease: From Molecular Mechanisms to Targeted Therapeutic Translation.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

Disrupting two Arabidopsis thaliana xylosyltransferase genes results in plants deficient in thermomorphogenesis.

The New phytologist·2026

Early Prophylactic Rituximab Reduces EBV Infection and PTLD in High-risk patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Transplantation and cellular therapy·2026

Electromechanical coupling in fascia and its link to collagen morphology.

Journal of the mechanical behavior of biomedical materials·2026

GSAman: A gene-structure annotation manual curator for functional genomics research.

Innovation (Cambridge (Mass.))·2026

Genetically determined heterogeneous treatment effects of Helicobacter pylori eradication for targeted gastric cancer prevention.

Innovation (Cambridge (Mass.))·2026

Tropical Atlantic and Pacific sea surface temperature gradients modulate the summer Atlantic Niño-winter ENSO connection.

Innovation (Cambridge (Mass.))·2026

Deciphering interventional dynamical causality from non-intervention complex systems.

Innovation (Cambridge (Mass.))·2026

Flexible ultrafast spintronic terahertz emitter with exceptional working temperature range.

Innovation (Cambridge (Mass.))·2026

Reactive hydrogen in KH or KOH for catalytic NH3 synthesis.

Innovation (Cambridge (Mass.))·2026

Correction: Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease: real-world evidence from a German University Hospital.

Frontiers in endocrinology·2026

Integration of hereditary thrombophilia data and polygenic risk scores into prognostic models improves differential diagnosis of CTEPH.

Frontiers in cardiovascular medicine·2026

Hybutimibe, an innovative cholesterol absorption inhibitor for lipid-lowering therapy: current evidence and future perspectives.

Frontiers in pharmacology·2026

Beyond traditional anticoagulants: exploring the future of thromboembolism treatment with FXI inhibitors.

Frontiers in immunology·2026

Living with angina: rethinking angina management in ANOCA through lived experience.

Frontiers in cardiovascular medicine·2026

Association of early neutrophil-to-lymphocyte ratio trajectories with cardiac recovery and live ICU discharge in patients with sepsis-induced cardiomyopathy: a retrospective cohort study.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us